Anal cancer statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of anal cancer, 2015-2017, UK.

Deaths

Deaths from anal cancer, 2015-2017, UK

 

Survival

Survive anal cancer for 10 or more years, 2013-2017, England

 

Preventable cases

Anal cancer cases are preventable, UK, 2015

 

  • There are around 1,500 new anal cancer cases in the UK every year, that's around 4 every day (2015-2017).
  • Anal cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017).
  • In females in the UK, anal cancer is not among the 20 most common cancers, with around 980 new cases in 2017.
  • In males in the UK, anal cancer is not among the 20 most common cancers, with around 510 new cases in 2017.
  • Incidence rates for anal cancer in the UK are highest in people aged 90+ (2015-2017).
  • Each year a quarter (25%) of all new anal cancer cases in the UK are diagnosed in people aged 75 and over (2015-2017).
  • Since the early 1990s, anal cancer incidence rates have increased by around three-quarters (76%) in the UK. Rates in females have increased by around two times (118%), and rates in males have increased by around a quarter (26%) (2015-2017).
  • Over the last decade, anal cancer incidence rates have increased by around two-fifths (41%) in the UK. Rates in males have increased by around a seventh (15%), and rates in females have increased by around three-fifths (59%) (2015-2017).
  • Anal cancer incidence rates are likely to fall in future decades, according to projections accounting for the expected impact of HPV vaccination.
  • Anal cancer incidence rates in England in females are 60% higher in the most deprived quintile compared with the least, and in males are 89% higher in the most deprived quintile compared with the least (2013-2017).
  • Around 260 cases of anal cancer each year in England are linked with deprivation (around 160 in females and around 100 in males).
  • An estimated 6,700 people who had previously been diagnosed with anal cancer were alive in the UK at the end of 2010.

See more in-depth anal cancer incidence statistics

  • There are around 400 anal cancer deaths in the UK every year, that's around 1 every day (2015-2017).
  • Anal cancer is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2017).
  • In females in the UK, anal cancer is not among the 20 most common causes of cancer death, with around 280 deaths in 2017.
  • In males in the UK, anal cancer is not among the 20 most common causes of cancer death, with around 160 deaths in 2017.
  • Mortality rates for anal cancer in the UK are highest in people aged 90+ (2015-2017).
  • Since the late 1970s, anal cancer mortality rates have increased by around two-thirds (65%) in the UK. Rates in females have increased by almost two times (97%), and rates in males have increased by around a third (32%).
  • Over the last decade, anal cancer mortality rates have increased by a third (33%) in the UK. Rates in females have increased by more than a third (36%), and rates in males have increased by almost a third (29%).
  • Mortality rates for anal cancer may fall in future decades.
  • Anal cancer deaths in England are more common in people living in the most deprived areas.

See more in-depth anal cancer mortality statistics

  • Almost 9 in 10 (84.8%) of people diagnosed with anal cancer in England survive their disease for one year or more (2013-2017).
  • Around 6 in 10 (58.7%) of people diagnosed with anal cancer in England survive their disease for five years or more (2013-2017).
  • It is predicted that more than 1 in 2 (52.2%) of people diagnosed with anal cancer in England survive their disease for ten years or more (2013-2017).
  • Anal cancer survival for females is higher than for males at one- and five-years.
  • Anal cancer five-year survival in England is highest for adults diagnosed aged under 50 years old (2009-2013).
  • More than three-quarters of people in England diagnosed with anal cancer aged 15-49 survive their disease for five years or more, compared with around half of people diagnosed aged 70-89 (2009-2013).
  • When diagnosed at its earliest stage, around all (99%) people with anal cancer will survive their disease for one year or more, compared with more than 1 in 2 (53%) people when the disease is diagnosed at the latest stage.
  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 676 UK males and 1 in 281 UK females will be diagnosed with anal cancer in their lifetime.
  • 91% of anal cancer cases in the UK are preventable.
  • 91% of anal cancer cases in the UK are caused by infections.

See more in-depth anal cancer risk statistics

  • 'GP referral' is the most common route to diagnosing anal cancer.
  • ‘Two-week wait’ standard is met by England, ‘31-day wait’ is met by all countries but Wales, and ‘62-day wait’ is not met by any country for lower gastrointestinal cancers.

See more in-depth anal cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs